Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outcome after prolonged sedation
DRKS00020237Phase 3Completed
- Sponsor
- Sedana Medical
- Start
- Jan 2020
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3 trial of isoflurane and propofol in acute respiratory distress syndrome (ARDS) and pulmonary edema (2 arms), sponsored by Sedana Medical. Started Jan 2020; status: completed.
02
Drugs
isofluranepropofol
03
Conditions
acute respiratory distress syndrome (ARDS)pulmonary edema
Beyond the preview
Go deeper on DRKS00020237.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00020237.